Ctrl/Cmd K

Loading stock analysis…

Explore

Stocks
Screener
IPOs
News

Tools

Backtest
Portfolio
Wealth
ITR

Learn

Guides
Methodology

Company

About
Contact
Disclosures
Privacy
Terms

© 2026 Anvest. All rights reserved.

Designed & Engineered in India·harsh@anvest.in

Disclaimer: Anvest provides financial analytics, screening simulations, and planning tools for informational and educational purposes only. Anvest is not a SEBI-registered investment advisor or broker. Nothing herein constitutes investment advice or an offer to buy/sell securities. Full details on methodology and limitations are documented under Disclosures and Terms.

Stocks›Healthcare

Wockhardt Limited

WOCKPHARMA · NSE · Healthcare · As of 30 Oct 2026Delayed / Sandbox EOD Data

₹1,901.10

−₹21.80 (−1.13%)(1D)

₹1,086.7052 Week Range₹2,422.30

Chart Score AI Profile Fundamentals Technicals Financials Shareholding Peers Filings

Anvest Score

37/100

Valuation

0/100

Quality

31/100

Growth

42/100

Health

55/100

Momentum

73/100

Valuation
0
Quality
31
Growth
42
Health
55
Momentum
73

Loading company profile…

Loading fundamentals…

Loading technical indicators…

Loading financial statement…

Loading shareholding…

Loading peer comparison…

Loading filings…

More Page Context

Research at a glance

Wockhardt Limited with delayed price, financials, ownership context, and peer links.

Latest price

₹1,901.1

Market cap

₹30,818 Cr

P/E ratio

75.44

P/B ratio

6.24

Dividend yield

Not available

ROE

Not available

RSI 14

42.97

1Y return

Not available

Wockhardt Limited FAQs

3 topics

ExpandCollapse

Related paths

Peer links appear when comparable names are available.

Open screener Curated screens Backtest ideas

What does the Wockhardt Limited (WOCKPHARMA) stock page cover?

Wockhardt Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for WOCKPHARMA?

Wockhardt Limited is currently shown with a delayed price near ₹1,901.1, P/E 75.44.

Does the WOCKPHARMA page provide investment advice?

No. The WOCKPHARMA page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Keep exploring

Related insights

PPLPHARMA

Piramal Pharma Limited · Healthcare

EMCURE

Emcure Pharmaceuticals Limited · Healthcare

NEULANDLAB

Neuland Laboratories Limited · Healthcare

No-Code AI Backtesting vs. Python Frameworks for Indian Retail Quants

Compare no-code backtesting platforms with custom Python stacks (Backtrader, VectorBT) for Indian equities. Evaluate data hygiene, corporate actions, and speed.

AI Company ProfileSign in to generate AI briefing

AI Snapshot

Wockhardt Limited is a prominent Indian pharmaceutical company specializing in generic and specialty drugs, operating both domestically and internationally. It focuses on research, development, manufacturing, and marketing a wide range of pharmaceutical products.

Drug Manufacturers - Specialty & GenericFounded:1967CEO/MD:Dr. Murtaza KhorakiwalaHQ:Mumbai, Maharashtra

Business at a Glance

Assurance provider is SGS India Private Limited.
Wockhardt generates revenue by researching, developing, manufacturing, and selling a diverse portfolio of pharmaceutical products, including generic formulations, specialty drugs, biopharmaceuticals, and vaccines.

What Looks Strong

Financial highlights are being recalculated.

What to Watch

Financial highlights are being recalculated.

Reports a single operating segment in its results filings.
They leverage their R&D capabilities and manufacturing facilities to serve both domestic and international markets.
The company's disclosures are made on a standalone basis for India Operations only.